0001209191-17-065402.txt : 20171213 0001209191-17-065402.hdr.sgml : 20171213 20171213154509 ACCESSION NUMBER: 0001209191-17-065402 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171213 DATE AS OF CHANGE: 20171213 EFFECTIVENESS DATE: 20171213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEPHROS INC CENTRAL INDEX KEY: 0001196298 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 133971809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-283400 FILM NUMBER: 171253808 BUSINESS ADDRESS: STREET 1: 380 LACKAWANNA PLACE CITY: SOUTH ORANGE STATE: NJ ZIP: 07079 BUSINESS PHONE: 201.343.5202 MAIL ADDRESS: STREET 1: 380 LACKAWANNA PLACE CITY: SOUTH ORANGE STATE: NJ ZIP: 07079 D/A 1 primary_doc.xml X0708 D/A LIVE 001196298 NEPHROS INC 380 Lackawanna Place South Orange NJ NEW JERSEY 07079 201-343-5202 DELAWARE None None Corporation true Daron Evans 380 Lackawanna Place South Orange NJ NEW JERSEY 07079 Executive Officer Director Paul Mieyal 380 Lackawanna Place South Orange NJ NEW JERSEY 07079 Director Arthur Amron 380 Lackawanna Place South Orange NJ NEW JERSEY 07079 Director Malcolm Persen 380 Lackawanna Place South Orange NJ NEW JERSEY 07079 Director Moshe Pinto 380 Lackawanna Place South Orange NJ NEW JERSEY 07079 Director Other Health Care Decline to Disclose 06b true 0001209191-17-022971 2017-03-17 true true true The underlying offering is complete and this amendment to the original Form D covers only the common stock issuable upon exercise of warrants sold in the underlying offering. false 0 2436000 1218000 1218000 The underlying offering is complete. The total amount sold reflects $1,218,000 of common stock sold in the offering and the total remaining to be sold reflects $1,218,000 of common stock issuable upon the exercise of warrants sold in the offering. false 19 0 0 The underlying offering is complete. The placement agent for such offering received warrants to purchase 81,199 shares of common stock. 100000 true Anticipated payment of executive officer salaries. false Nephros Inc /s/ Daron Evans Daron Evans Chief Executive Officer 2017-12-13